Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1996 2
1999 1
2001 1
2005 5
2006 3
2007 5
2008 4
2009 3
2010 8
2011 5
2012 8
2013 11
2014 4
2015 6
2016 8
2017 7
2018 13
2019 14
2020 12
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Results by year
Filters applied: . Clear all
Page 1
P-glycoprotein: a clue to vitamin K antagonist stabilization.
Gschwind L, Rollason V, Boehlen F, Rebsamen M, Combescure C, Matthey A, Bonnabry P, Dayer P, Desmeules JA. Gschwind L, et al. Pharmacogenomics. 2015 Jan;16(2):129-36. doi: 10.2217/pgs.14.164. Pharmacogenomics. 2015. PMID: 25616099
The results of the clinical study showed that carriers of ABCB1 c.3435TT were more rapidly stabilized than wild-type patients (HR: 2.97, 95% CI: 1.23-7.18; p = 0.02). The same tendency was observed for the ABCB1 c.2677GT and 2677TT genotypes compared with ABCB1 c.2677GG. T …
The results of the clinical study showed that carriers of ABCB1 c.3435TT were more rapidly stabilized than wild-type patients (HR: 2.97, 95% …
Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model.
Gschwind L, Rollason V, Daali Y, Bonnabry P, Dayer P, Desmeules JA. Gschwind L, et al. Basic Clin Pharmacol Toxicol. 2013 Oct;113(4):259-65. doi: 10.1111/bcpt.12084. Epub 2013 Jun 25. Basic Clin Pharmacol Toxicol. 2013. PMID: 23663291 Free article.
The efflux of rivaroxaban was strongly inhibited by the two P-gp inhibitors. In conclusion, none of the three VKAs tested are strong P-gp substrates. However, acenocoumarol can be considered as a weak P-gp substrate and phenprocoumon as a poor P-gp sub …
The efflux of rivaroxaban was strongly inhibited by the two P-gp inhibitors. In conclusion, none of the three VKAs tested are strong …
Immunosuppressant therapeutic drug monitoring and trough level stabilisation after paediatric liver or kidney transplantation.
Posfay-Barbe KM, Baudet H, McLin VA, Parvex P, Chehade H, Combescure C, Bonnabry P, Fonzo-Christe C. Posfay-Barbe KM, et al. Swiss Med Wkly. 2019 Dec 4;149:w20156. doi: 10.4414/smw.2019.20156. eCollection 2019 Dec 2. Swiss Med Wkly. 2019. PMID: 31800965 Free article.
In KT, trough levels stabilised earlier for tacrolimus than for ciclosporin (p = 0.02). Intensive care and hospital discharge occurred earlier in KT patients (p <0.001). Living-donor LT was associated with an earlier intensive care discharge compared with dec …
In KT, trough levels stabilised earlier for tacrolimus than for ciclosporin (p = 0.02). Intensive care and hospital discharge occurre …
109 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page